REG - EKF Diagnostics Hldg - Board Changes

EKF Diagnostics HoldingsAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260427:nRSa9952Ba&default-theme=true

RNS Number : 9952B  EKF Diagnostics Holdings PLC  27 April 2026

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Board Changes

Appointment of Chief Financial Officer

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-quoted global diagnostics
business, announces the appointment of Helen Jones FCA as Chief Financial
Officer ("CFO"). Helen will join the Board and assume the role of CFO with
immediate effect.

 

Helen Jones is an experienced CFO with over 20 years' experience leading
finance, operations, and strategic transactions in high-growth,
technology-driven AIM listed businesses.

 

Helen joins EKF from Surgical Science, a leading provider of medical
simulation solutions, where she has assumed a senior Group-level role
following its acquisition of Intelligent Ultrasound Group plc in February
2025, with responsibility spanning post-acquisition integration and
operational cost reduction, Group statutory reporting, and sustainability
leadership. Prior to the acquisition, Helen spent five years as CFO of
Intelligent Ultrasound Group plc, an AIM-listed company supplying simulation
and AI-based ultrasound training solutions to the healthcare sector. During
her tenure, Helen led two successful equity placings to fund growth and
innovation, played a central role in both the £40.6 million divestment of its
Clinical AI division to GE Healthcare and the subsequent sale of the
Simulation business to Surgical Science.

 

Before joining Intelligent Ultrasound, Helen held a senior finance role within
AIM-listed oil and exploration company Amerisur Resources plc and prior to
that spent 11 years in various senior financial positions at Tata Steel
Europe. Helen is a fellow of the Institute of Chartered Accountants in England
and Wales having trained and qualified with PwC in 2004.

 

Helen succeeds Stephen Young, who is retiring from the Board. Steve will be
available to support Helen to ensure a smooth handover but will step down from
the Board with immediate effect. The Board would like to extend its sincere
thanks to Steve for his financial stewardship since joining the Company in
September 2023 and wishes him well in his retirement.

 

 

Commenting, Gavin Jones, Chief Executive Officer, said: "We are delighted to
welcome Helen to the EKF team at a key time as we execute on our five-year
development plan for accelerated growth. Helen's track record in listed
healthcare technology businesses, her experience executing complex
transactions, and her capital markets expertise make her an excellent fit for
EKF as we accelerate our five-year plan. Her appointment reflects our
commitment to building a leadership team capable of delivering our ambitious
growth targets."

 

Additional Disclosures Required under the AIM Rules for Companies

The following additional information is provided with regards to the
appointment of Helen Mary Kinsey Jones (aged 47) in accordance with AIM Rule
17 and Schedule 2(g) of the AIM Rules for Companies:

 

 Current Directorships/partnerships  Directorships/partnerships within the last five years:
 None                                IML Finance Limited
                                     Intelligent Ultrasound Innovations Limited
                                     Intelligent Ultrasound Limited
                                     Intelligent Ultrasound North America Inc
                                     Inventive Medical Limited
                                     Medaphor International Limited
                                     Surgical Science UK Limited
                                     Surgical Science UK Holdings Limited

 

Helen does not hold any shares or options in the Company.

 

There are no further disclosures required under Rule 17 and Schedule 2(g) of
the AIM Rules for Companies.

 

The person responsible for arranging the release of this Announcement

on behalf of the Company is Gavin Jones, Chief Executive Officer.

 

 EKF Diagnostics Holdings plc                                www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Julian Baines, Executive Chair                               via Walbrook PR
 Gavin Jones, Chief Executive Officer

 Singer Capital Markets (Nominated Adviser & Broker)                                       Tel: +44 (0)20 7496 3000
 Phil Davies / Patrick Weaver

 Walbrook PR Limited              Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Alice Woodings    Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

 

EKF is an AIM-listed global diagnostics business focussed on:

 

 ●    Point-of-Care analysers in the key areas of Hematology and Diabetes
 ●    Life Sciences services provide specialist manufacture of enzymes and custom
      products for use in diagnostic, food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing
sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASEAESMEMSEFL



            Copyright 2019 Regulatory News Service, all rights reserved